Evidence map›Paper›PMID 20808032›Full record

ArticleNanotechnology2010

Slowing the translocation of double-stranded DNA using a nanopore smaller than the double helix.

Utkur Mirsaidov, Jeffrey Comer, Valentin Dimitrov, Aleksei Aksimentiev, Gregory Timp

Abstract read
In one paragraph

Article in Nanotechnology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Utkur MirsaidovBeckman Institute, University of Illinois, Urbana, IL 61801, USA.
Jeffrey Comer
Valentin Dimitrov
Aleksei Aksimentiev
Gregory Timp

Funding

WHOLE CELL SIMULATIONP41RR005969 · NCRR · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI STONE, JOHN H · 1990 to 2011
$19.8M
Sequencing a DNA molecule using a Synthetic NanoporeR01HG003713 · NHGRI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI TIMP, GREGORY LOUIS · 2005 to 2008
$2.4M
NEW APPROACHES TO DNA MAPPING--ELECTRONIC IMAGINGR01HG000371 · NHGRI · ASSOCIATED UNIV-BROOKHAVEN NATL LAB · PI SUTHERLAND, JOHN C · 1990 to 1992
–
NCRR NIH HHS 5 P41-RR05969NCRR NIH HHS P41 RR005969NHGRI NIH HHS R01 HG003713NHGRI NIH HHS R01 HG003713A
6 · The paper itself

Abstract

It is now possible to slow and trap a single molecule of double-stranded DNA (dsDNA), by stretching it using a nanopore, smaller in diameter than the double helix, in a solid-state membrane. By applying an electric force larger than the threshold for stretching, dsDNA can be impelled through the pore. Once a current blockade associated with a translocating molecule is detected, the electric field in the pore is switched in an interval less than the translocation time to a value below the threshold for stretching. According to molecular dynamics (MD) simulations, this leaves the dsDNA stretched in the pore constriction with the base-pairs tilted, while the B-form canonical structure is preserved outside the pore. In this configuration, the translocation velocity is substantially reduced from 1 bp/10 ns to approximately 1 bp/2 ms in the extreme, potentially facilitating high fidelity reads for sequencing, precise sorting, and high resolution (force) spectroscopy.

Indexed as

Molecular Dynamics SimulationBacteriophage lambdaDNADNA, ViralElectrochemical TechniquesMicroscopy, Electron, TransmissionNanoporesNanotechnologyNucleic Acid ConformationParticle SizeDNADNA, Viral

Identifiers

PMID20808032
PMCPMC3170403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.